SCHEMBL16349582

SCHEMBL16349582

CC(=O)C(=O)[C@@H]1CCCCCCCCCC[C@H](NC(=O)NC2(C)CCCCC2)C(=O)N2C[C@H]3[C@@H]([C@H]2C(=O)N1)C3(C)C

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ CCR2 P41597 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12607828 0.94 CCR2 (0.31) CCR2
SCHEMBL16349676 0.90 — —
SCHEMBL16349619 0.90 — —
SCHEMBL16315723 0.87 CTSV (0.31) —
SCHEMBL16349744 0.85 — —
SCHEMBL12607088 0.84 — —
SCHEMBL13685073 0.84 — —
SCHEMBL13685097 0.84 — —
SCHEMBL16349734 0.82 GAA (0.35) —
SCHEMBL16315715 0.82 GAA (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7592419-B2 Macrocyclic inhibitors of hepatitis C virus NS3-serine protease SCHERING CORPORATION (US) 2009-09-22 — — US disclosed
Send feedback